Economy & Marketsnational✓ verified · 90%
8-K material event: Neumora Therapeutics, Inc.
- When
- Where
- US
- Category
- corporate_filing · form_8k
Filed: 2026-06-15 AccNo: 0001193125-26-270328 Size: 185 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 2.05: Cost Associated with Exit or Disposal Activities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Sources
- SEC EDGAR ↗ · first seen 2026-06-15 12:15 UTC
Defaxon links out to the original reporting and never republishes article text.
Correlated events
Computed by the Defaxon correlation engine — linked by shared actors, co-location, and temporal proximity. Scored hypotheses, never causal claims.